Back
ESC2025 Premium Access

Predictors and outcomes of amyloid cardiomyopathy caused by transthyretin V30 mutation

Session: Shedding light on transthyretin cardiac amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Doctor M. Pereira Santos (Porto, PT)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Mariana Pereira Santos

Hospital University Center of Porto, Porto (Portugal)
1 follower

7 more presentations in this session

Nutritional status and its impact on transthyretin cardiac amyloidosis: unraveling connection

Speaker: Mrs P. Lujan Garcia (Las Palmas de Gran Canaria, ES)

Access
Abstract
Slides
Video
Like
Thumbnail

Plasma transthyretin fractions in transthyretin cardiac amyloidosis patients undergoing tafamidis treatment

Speaker: Doctor V. Castiglione (Pisa, IT)

Access
Abstract
Slides
Video
Like
Thumbnail

Lifetime physical and athletic activity as novel risk factors in the development of wild-type transthyretin amyloid cardiomyopathy - a multicenter cohort study

Speaker: Doctor N. Schwegel (Graz, AT)

Access
Abstract
Slides
Video
Like
Thumbnail

A review of routine bone scintigraphy reports for identification of incidental myocardial tracer uptake indicating cardiac amyloidosis

Speaker: Mr D. Hutt (London, GB)

Access
Abstract
Slides
Video
Like
Thumbnail

Unraveling gender differences in hereditary transthyretin amyloidosis: insights from the REACT registry

Speaker: Miss L. Freire (Sao Paulo, BR)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Shedding light on transthyretin cardiac amyloidosis

Speakers: Doctor M. Pereira Santos, Mrs P. Lujan Garcia, Doctor V. Castiglione, Doctor N. Schwegel, Mr D. Hutt...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources